GlassScriptPhysician profile
Sydney Meadows
NPI 1396361473
$669.22
in general payments reported to CMS, 2019-2025
10 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.28 · 2022: $84.08 · 2023: $148 · 2024: $70.31 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $147.85 | 2023 | Brixadi |
| Abbvie INC. | $104.37 | 2025 | |
| Neurocrine Biosciences, INC. | $85.13 | 2025 | |
| Indivior INC. | $84.08 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $74.77 | 2024-2025 | Uzedy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $74.60 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $34.35 | 2024-2025 | Abilify Maintena, Abilify Asimtufii |
| Sunovion Pharmaceuticals INC. | $28.28 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.39 | 2024 | Cobenfy |
| Janssen Pharmaceuticals, INC | $17.40 | 2025 | Invega Sustenna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sydney Meadows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.